APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

FGF-2 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FGF-2 Inhibitors Industry Growth and Trends Forecast to 2032

Report ID 173991550129 December 2025112 pages

Choose your research edition.

Industry ResearchFGF-2 Inhibitors Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal FGF-2 Inhibitors Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal FGF-2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FGF-2 Inhibitors Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal FGF-2 Inhibitors Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global FGF-2 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FGF-2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FGF-2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FGF-2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the FGF-2 Inhibitors market include Advenchen Laboratories, ArQule, AVEO Pharmaceuticals, Batu Biologics, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celon Pharma, Debiopharm International and Eddingpharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FGF-2 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FGF-2 Inhibitors market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FGF-2 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FGF-2 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global FGF-2 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FGF-2 Inhibitors Market by Company

Advenchen Laboratories

ArQule

AVEO Pharmaceuticals

Batu Biologics

Boehringer Ingelheim

Bristol-Myers Squibb Company

Celon Pharma

Debiopharm International

Eddingpharm

Eli Lilly and Company

Hutchison MediPharma

Principia Biopharma

Santa Cruz Biotechnology

Vichem Chemie Research

AstraZeneca

Amgen

Novartis

Eisai

FGF-2 Inhibitors Segment by Type

EDP-317

Debio-1347

CPL-043

BAY-1163877

AZD-4547

ASP-5878

Others

FGF-2 Inhibitors Segment by Application

Clinic

Hospital

Others

FGF-2 Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FGF-2 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FGF-2 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FGF-2 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of FGF-2 Inhibitors companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global FGF-2 Inhibitors Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global FGF-2 Inhibitors Market Size by Region (2021-2026) & (US$ Million) Table 3. Global FGF-2 Inhibitors Market Share by Region (2021-2026) Table 4. Global FGF-2 Inhibitors Market Size by Region (2027-2032) & (US$ Million) Table 5. Global FGF-2 Inhibitors Market Share by Region (2027-2032) Table 6. Global FGF-2 Inhibitors Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global FGF-2 Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 8. Global FGF-2 Inhibitors Market Size Share by Type (2021-2026) Table 9. Global FGF-2 Inhibitors Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global FGF-2 Inhibitors Market Size Share Forecasted by Type (2027-2032) Table 11. North America FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America FGF-2 Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe FGF-2 Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America FGF-2 Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global FGF-2 Inhibitors Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global FGF-2 Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 23. Global FGF-2 Inhibitors Market Size Share by Application (2021-2026) Table 24. Global FGF-2 Inhibitors Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global FGF-2 Inhibitors Market Size Share Forecasted by Application (2027-2032) Table 26. North America FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America FGF-2 Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe FGF-2 Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America FGF-2 Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. FGF-2 Inhibitors Industry Trends Table 37. FGF-2 Inhibitors Industry Drivers Table 38. FGF-2 Inhibitors Industry Opportunities and Challenges Table 39. FGF-2 Inhibitors Industry Restraints Table 40. Global FGF-2 Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 41. Global FGF-2 Inhibitors Revenue Market Share by Company (2021-2026) Table 42. Global FGF-2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global FGF-2 Inhibitors Key Company Headquarters & Area Served Table 44. Global FGF-2 Inhibitors Company, Product Type & Application Table 45. Global FGF-2 Inhibitors Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global FGF-2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Advenchen Laboratories Company Information Table 49. Advenchen Laboratories Business Overview Table 50. Advenchen Laboratories FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Advenchen Laboratories FGF-2 Inhibitors Product Portfolio Table 52. Advenchen Laboratories Recent Development Table 53. ArQule Company Information Table 54. ArQule Business Overview Table 55. ArQule FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ArQule FGF-2 Inhibitors Product Portfolio Table 57. ArQule Recent Development Table 58. AVEO Pharmaceuticals Company Information Table 59. AVEO Pharmaceuticals Business Overview Table 60. AVEO Pharmaceuticals FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AVEO Pharmaceuticals FGF-2 Inhibitors Product Portfolio Table 62. AVEO Pharmaceuticals Recent Development Table 63. Batu Biologics Company Information Table 64. Batu Biologics Business Overview Table 65. Batu Biologics FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Batu Biologics FGF-2 Inhibitors Product Portfolio Table 67. Batu Biologics Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim FGF-2 Inhibitors Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Bristol-Myers Squibb Company Company Information Table 74. Bristol-Myers Squibb Company Business Overview Table 75. Bristol-Myers Squibb Company FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bristol-Myers Squibb Company FGF-2 Inhibitors Product Portfolio Table 77. Bristol-Myers Squibb Company Recent Development Table 78. Celon Pharma Company Information Table 79. Celon Pharma Business Overview Table 80. Celon Pharma FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Celon Pharma FGF-2 Inhibitors Product Portfolio Table 82. Celon Pharma Recent Development Table 83. Debiopharm International Company Information Table 84. Debiopharm International Business Overview Table 85. Debiopharm International FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Debiopharm International FGF-2 Inhibitors Product Portfolio Table 87. Debiopharm International Recent Development Table 88. Eddingpharm Company Information Table 89. Eddingpharm Business Overview Table 90. Eddingpharm FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eddingpharm FGF-2 Inhibitors Product Portfolio Table 92. Eddingpharm Recent Development Table 93. Eli Lilly and Company Company Information Table 94. Eli Lilly and Company Business Overview Table 95. Eli Lilly and Company FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eli Lilly and Company FGF-2 Inhibitors Product Portfolio Table 97. Eli Lilly and Company Recent Development Table 98. Hutchison MediPharma Company Information Table 99. Hutchison MediPharma Business Overview Table 100. Hutchison MediPharma FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hutchison MediPharma FGF-2 Inhibitors Product Portfolio Table 102. Hutchison MediPharma Recent Development Table 103. Principia Biopharma Company Information Table 104. Principia Biopharma Business Overview Table 105. Principia Biopharma FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Principia Biopharma FGF-2 Inhibitors Product Portfolio Table 107. Principia Biopharma Recent Development Table 108. Santa Cruz Biotechnology Company Information Table 109. Santa Cruz Biotechnology Business Overview Table 110. Santa Cruz Biotechnology FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Santa Cruz Biotechnology FGF-2 Inhibitors Product Portfolio Table 112. Santa Cruz Biotechnology Recent Development Table 113. Vichem Chemie Research Company Information Table 114. Vichem Chemie Research Business Overview Table 115. Vichem Chemie Research FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Vichem Chemie Research FGF-2 Inhibitors Product Portfolio Table 117. Vichem Chemie Research Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AstraZeneca FGF-2 Inhibitors Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Amgen Company Information Table 124. Amgen Business Overview Table 125. Amgen FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Amgen FGF-2 Inhibitors Product Portfolio Table 127. Amgen Recent Development Table 128. Novartis Company Information Table 129. Novartis Business Overview Table 130. Novartis FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Novartis FGF-2 Inhibitors Product Portfolio Table 132. Novartis Recent Development Table 133. Eisai Company Information Table 134. Eisai Business Overview Table 135. Eisai FGF-2 Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Eisai FGF-2 Inhibitors Product Portfolio Table 137. Eisai Recent Development Table 138. North America FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America FGF-2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 140. North America FGF-2 Inhibitors Market Share by Country (2021-2026) Table 141. North America FGF-2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America FGF-2 Inhibitors Market Share Forecast by Country (2027-2032) Table 143. Europe FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe FGF-2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe FGF-2 Inhibitors Market Share by Country (2021-2026) Table 146. Europe FGF-2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe FGF-2 Inhibitors Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific FGF-2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific FGF-2 Inhibitors Market Share by Country (2021-2026) Table 151. Asia-Pacific FGF-2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific FGF-2 Inhibitors Market Share Forecast by Country (2027-2032) Table 153. Latin America FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America FGF-2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America FGF-2 Inhibitors Market Share by Country (2021-2026) Table 156. Latin America FGF-2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America FGF-2 Inhibitors Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa FGF-2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa FGF-2 Inhibitors Market Share by Country (2021-2026) Table 161. Middle East & Africa FGF-2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa FGF-2 Inhibitors Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. FGF-2 Inhibitors Product Image Figure 3. Global FGF-2 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global FGF-2 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 5. Global FGF-2 Inhibitors Market Share by Region: 2025 VS 2032 Figure 6. Global FGF-2 Inhibitors Market Share by Region (2021-2032) Figure 7. North America FGF-2 Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe FGF-2 Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific FGF-2 Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America FGF-2 Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa FGF-2 Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. EDP-317 Image Figure 13. Global EDP-317 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Debio-1347 Image Figure 15. Global Debio-1347 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. CPL-043 Image Figure 17. Global CPL-043 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. BAY-1163877 Image Figure 19. Global BAY-1163877 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. AZD-4547 Image Figure 21. Global AZD-4547 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. ASP-5878 Image Figure 23. Global ASP-5878 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Others Image Figure 25. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global FGF-2 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global FGF-2 Inhibitors Market Share by Type 2025 VS 2032 Figure 28. North America FGF-2 Inhibitors Market Size Share by Type (2021-2032) Figure 29. Europe FGF-2 Inhibitors Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific FGF-2 Inhibitors Market Size Share by Type (2021-2032) Figure 31. Latin America FGF-2 Inhibitors Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa FGF-2 Inhibitors Market Size Share by Type (2021-2032) Figure 33. Clinic Image Figure 34. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Hospital Image Figure 36. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global FGF-2 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global FGF-2 Inhibitors Market Share by Application 2025 VS 2032 Figure 41. North America FGF-2 Inhibitors Market Size Share by Application (2021-2032) Figure 42. Europe FGF-2 Inhibitors Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific FGF-2 Inhibitors Market Size Share by Application (2021-2032) Figure 44. Latin America FGF-2 Inhibitors Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa FGF-2 Inhibitors Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 FGF-2 Inhibitors Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America FGF-2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America FGF-2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America FGF-2 Inhibitors Market Share by Country (2021-2032) Figure 51. Europe FGF-2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe FGF-2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe FGF-2 Inhibitors Market Share by Country (2021-2032) Figure 54. Asia-Pacific FGF-2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific FGF-2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific FGF-2 Inhibitors Market Share by Country (2021-2032) Figure 57. Latin America FGF-2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America FGF-2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America FGF-2 Inhibitors Market Share by Country (2021-2032) Figure 60. Middle East & Africa FGF-2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa FGF-2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa FGF-2 Inhibitors Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • EDP-317
  • Debio-1347
  • CPL-043
  • BAY-1163877
  • AZD-4547
  • ASP-5878
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Advenchen Laboratories
  • ArQule
  • AVEO Pharmaceuticals
  • Batu Biologics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Celon Pharma
  • Debiopharm International
  • Eddingpharm
  • Eli Lilly and Company
  • Hutchison MediPharma
  • Principia Biopharma
  • Santa Cruz Biotechnology
  • Vichem Chemie Research
  • AstraZeneca
  • Amgen
  • Novartis
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global FGF-2 Inhibitors Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global FGF-2 Inhibitors Market Size by Region (2021-2032)
  5. 1.4.1 Global FGF-2 Inhibitors Market Size by Region (2021-2026)
  6. 1.4.2 Global FGF-2 Inhibitors Market Size by Region (2027-2032)
  7. 1.5 Key Regions FGF-2 Inhibitors Market Size (2021-2032)
  8. 1.5.1 North America FGF-2 Inhibitors Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe FGF-2 Inhibitors Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific FGF-2 Inhibitors Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America FGF-2 Inhibitors Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa FGF-2 Inhibitors Market Size Growth Rate (2021-2032)
2 FGF-2 Inhibitors Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 EDP-317
  3. 2.1.2 Debio-1347
  4. 2.1.3 CPL-043
  5. 2.1.4 BAY-1163877
  6. 2.1.5 AZD-4547
  7. 2.1.6 ASP-5878
  8. 2.1.7 Others
  9. 2.2 Global FGF-2 Inhibitors Market Size by Type
  10. 2.2.1 Global FGF-2 Inhibitors Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global FGF-2 Inhibitors Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global FGF-2 Inhibitors Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global FGF-2 Inhibitors Market Size by Regions
  14. 2.3.1 North America FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Type (2021-2026)
3 FGF-2 Inhibitors Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinic
  3. 3.1.2 Hospital
  4. 3.1.3 Others
  5. 3.2 Global FGF-2 Inhibitors Market Size by Application
  6. 3.2.1 Global FGF-2 Inhibitors Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global FGF-2 Inhibitors Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global FGF-2 Inhibitors Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global FGF-2 Inhibitors Market Size by Regions
  10. 3.3.1 North America FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa FGF-2 Inhibitors Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 FGF-2 Inhibitors Industry Trends
  2. 4.2 FGF-2 Inhibitors Industry Drivers
  3. 4.3 FGF-2 Inhibitors Industry Opportunities and Challenges
  4. 4.4 FGF-2 Inhibitors Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by FGF-2 Inhibitors Revenue (2021-2026)
  2. 5.2 Global FGF-2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global FGF-2 Inhibitors Key Company Headquarters & Area Served
  4. 5.4 Global FGF-2 Inhibitors Company, Product Type & Application
  5. 5.5 Global FGF-2 Inhibitors Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global FGF-2 Inhibitors Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 FGF-2 Inhibitors Players Market Share by Revenue in 2025
  9. 5.6.3 2025 FGF-2 Inhibitors Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Advenchen Laboratories
  2. 6.1.1 Advenchen Laboratories Company Information
  3. 6.1.2 Advenchen Laboratories Business Overview
  4. 6.1.3 Advenchen Laboratories FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Advenchen Laboratories FGF-2 Inhibitors Product Portfolio
  6. 6.1.5 Advenchen Laboratories Recent Developments
  7. 6.2 ArQule
  8. 6.2.1 ArQule Company Information
  9. 6.2.2 ArQule Business Overview
  10. 6.2.3 ArQule FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ArQule FGF-2 Inhibitors Product Portfolio
  12. 6.2.5 ArQule Recent Developments
  13. 6.3 AVEO Pharmaceuticals
  14. 6.3.1 AVEO Pharmaceuticals Company Information
  15. 6.3.2 AVEO Pharmaceuticals Business Overview
  16. 6.3.3 AVEO Pharmaceuticals FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AVEO Pharmaceuticals FGF-2 Inhibitors Product Portfolio
  18. 6.3.5 AVEO Pharmaceuticals Recent Developments
  19. 6.4 Batu Biologics
  20. 6.4.1 Batu Biologics Company Information
  21. 6.4.2 Batu Biologics Business Overview
  22. 6.4.3 Batu Biologics FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Batu Biologics FGF-2 Inhibitors Product Portfolio
  24. 6.4.5 Batu Biologics Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim FGF-2 Inhibitors Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
  31. 6.6 Bristol-Myers Squibb Company
  32. 6.6.1 Bristol-Myers Squibb Company Company Information
  33. 6.6.2 Bristol-Myers Squibb Company Business Overview
  34. 6.6.3 Bristol-Myers Squibb Company FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Company FGF-2 Inhibitors Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 6.7 Celon Pharma
  38. 6.7.1 Celon Pharma Company Information
  39. 6.7.2 Celon Pharma Business Overview
  40. 6.7.3 Celon Pharma FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Celon Pharma FGF-2 Inhibitors Product Portfolio
  42. 6.7.5 Celon Pharma Recent Developments
  43. 6.8 Debiopharm International
  44. 6.8.1 Debiopharm International Company Information
  45. 6.8.2 Debiopharm International Business Overview
  46. 6.8.3 Debiopharm International FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Debiopharm International FGF-2 Inhibitors Product Portfolio
  48. 6.8.5 Debiopharm International Recent Developments
  49. 6.9 Eddingpharm
  50. 6.9.1 Eddingpharm Company Information
  51. 6.9.2 Eddingpharm Business Overview
  52. 6.9.3 Eddingpharm FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eddingpharm FGF-2 Inhibitors Product Portfolio
  54. 6.9.5 Eddingpharm Recent Developments
  55. 6.10 Eli Lilly and Company
  56. 6.10.1 Eli Lilly and Company Company Information
  57. 6.10.2 Eli Lilly and Company Business Overview
  58. 6.10.3 Eli Lilly and Company FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eli Lilly and Company FGF-2 Inhibitors Product Portfolio
  60. 6.10.5 Eli Lilly and Company Recent Developments
  61. 6.11 Hutchison MediPharma
  62. 6.11.1 Hutchison MediPharma Company Information
  63. 6.11.2 Hutchison MediPharma Business Overview
  64. 6.11.3 Hutchison MediPharma FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hutchison MediPharma FGF-2 Inhibitors Product Portfolio
  66. 6.11.5 Hutchison MediPharma Recent Developments
  67. 6.12 Principia Biopharma
  68. 6.12.1 Principia Biopharma Company Information
  69. 6.12.2 Principia Biopharma Business Overview
  70. 6.12.3 Principia Biopharma FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Principia Biopharma FGF-2 Inhibitors Product Portfolio
  72. 6.12.5 Principia Biopharma Recent Developments
  73. 6.13 Santa Cruz Biotechnology
  74. 6.13.1 Santa Cruz Biotechnology Company Information
  75. 6.13.2 Santa Cruz Biotechnology Business Overview
  76. 6.13.3 Santa Cruz Biotechnology FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Santa Cruz Biotechnology FGF-2 Inhibitors Product Portfolio
  78. 6.13.5 Santa Cruz Biotechnology Recent Developments
  79. 6.14 Vichem Chemie Research
  80. 6.14.1 Vichem Chemie Research Company Information
  81. 6.14.2 Vichem Chemie Research Business Overview
  82. 6.14.3 Vichem Chemie Research FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Vichem Chemie Research FGF-2 Inhibitors Product Portfolio
  84. 6.14.5 Vichem Chemie Research Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca FGF-2 Inhibitors Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 Amgen
  92. 6.16.1 Amgen Company Information
  93. 6.16.2 Amgen Business Overview
  94. 6.16.3 Amgen FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Amgen FGF-2 Inhibitors Product Portfolio
  96. 6.16.5 Amgen Recent Developments
  97. 6.17 Novartis
  98. 6.17.1 Novartis Company Information
  99. 6.17.2 Novartis Business Overview
  100. 6.17.3 Novartis FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Novartis FGF-2 Inhibitors Product Portfolio
  102. 6.17.5 Novartis Recent Developments
  103. 6.18 Eisai
  104. 6.18.1 Eisai Company Information
  105. 6.18.2 Eisai Business Overview
  106. 6.18.3 Eisai FGF-2 Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Eisai FGF-2 Inhibitors Product Portfolio
  108. 6.18.5 Eisai Recent Developments
7 North America
  1. 7.1 North America FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America FGF-2 Inhibitors Market Size by Country (2021-2026)
  3. 7.3 North America FGF-2 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe FGF-2 Inhibitors Market Size by Country (2021-2026)
  3. 8.3 Europe FGF-2 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific FGF-2 Inhibitors Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific FGF-2 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America FGF-2 Inhibitors Market Size by Country (2021-2026)
  3. 10.3 South America FGF-2 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa FGF-2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa FGF-2 Inhibitors Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa FGF-2 Inhibitors Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst